Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Capolla

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Nanomedicine (London, England)|January 15, 2025
Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinomaMonica Mossenta, Monica Argenziano, Sara Capolla, et al.
Journal of Hematology & Oncology|October 24, 2014
Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemiaSara Dereani, Paolo Macor, Tiziana D'Agaro, et al.
Nanomedicine (London, England)|December 2, 2024
The anti-glypican 1 AT101 antibody as targeting agent to effectively deliver chitosan nanobubbles to glioblastoma cellsFederica Di Cintio, Monica Argenziano, Anna Scomparin, et al.
Clinical Immunology (Orlando, Fla.)|January 7, 2016
Mast cells contribute to autoimmune diabetes by releasing interleukin-6 and failing to acquire a tolerogenic IL-10<sup>+</sup> phenotypeElena Betto, Vera Usuelli, Alessandra Mandelli, et al.
Journal of Nanobiotechnology|October 14, 2023
Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticlesSara Capolla, Federico Colombo, Luca De Maso, et al.
Probiotics and Antimicrobial Proteins|June 5, 2025
Mechanistic Divergence and Differential Antibacterial Potency of the Proline-Rich Antimicrobial Peptide B7-005 Across ESKAPE + E PathogensAdriana Di Stasi, Sara Capolla, Martino Morici, et al.
Frontiers in Immunology|June 26, 2023
Targeted chitosan nanobubbles as a strategy to down-regulate microRNA-17 into B-cell lymphoma modelsSara Capolla, Monica Argenziano, Sara Bozzer, et al.
Haematologica|September 29, 2022
Plasminogen activator-coated nanobubbles targeting cellbound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategyPaolo Macor, Paolo Durigutto, Monica Argenziano, et al.
Cancers|July 2, 2021
Constitutive PSGL-1 Correlates with CD30 and TCR Pathways and Represents a Potential Target for Immunotherapy in Anaplastic Large T-Cell LymphomaBeatrice Belmonte, Valeria Cancila, Alessandro Gulino, et al.
Plos One|October 8, 2013
New potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticlesNelly Mezzaroba, Sonia Zorzet, Erika Secco, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Nanomedicine (London, England)|January 15, 2025
Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinomaMonica Mossenta, Monica Argenziano, Sara Capolla, et al.
Journal of Hematology & Oncology|October 24, 2014
Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemiaSara Dereani, Paolo Macor, Tiziana D'Agaro, et al.
Nanomedicine (London, England)|December 2, 2024
The anti-glypican 1 AT101 antibody as targeting agent to effectively deliver chitosan nanobubbles to glioblastoma cellsFederica Di Cintio, Monica Argenziano, Anna Scomparin, et al.
Clinical Immunology (Orlando, Fla.)|January 7, 2016
Mast cells contribute to autoimmune diabetes by releasing interleukin-6 and failing to acquire a tolerogenic IL-10<sup>+</sup> phenotypeElena Betto, Vera Usuelli, Alessandra Mandelli, et al.
Journal of Nanobiotechnology|October 14, 2023
Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticlesSara Capolla, Federico Colombo, Luca De Maso, et al.
Probiotics and Antimicrobial Proteins|June 5, 2025
Mechanistic Divergence and Differential Antibacterial Potency of the Proline-Rich Antimicrobial Peptide B7-005 Across ESKAPE + E PathogensAdriana Di Stasi, Sara Capolla, Martino Morici, et al.
Frontiers in Immunology|June 26, 2023
Targeted chitosan nanobubbles as a strategy to down-regulate microRNA-17 into B-cell lymphoma modelsSara Capolla, Monica Argenziano, Sara Bozzer, et al.
Haematologica|September 29, 2022
Plasminogen activator-coated nanobubbles targeting cellbound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategyPaolo Macor, Paolo Durigutto, Monica Argenziano, et al.
Cancers|July 2, 2021
Constitutive PSGL-1 Correlates with CD30 and TCR Pathways and Represents a Potential Target for Immunotherapy in Anaplastic Large T-Cell LymphomaBeatrice Belmonte, Valeria Cancila, Alessandro Gulino, et al.
Plos One|October 8, 2013
New potential therapeutic approach for the treatment of B-Cell malignancies using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticlesNelly Mezzaroba, Sonia Zorzet, Erika Secco, et al.
Pageof 2